Creatine HCL Dosage: How Much to Take and When

Creatine HCL dosing is straightforward. Unlike monohydrate, where loading protocols and larger daily doses are common, creatine HCL is typically used at 1-2 g/day from the start. Below is what the available evidence supports.

What Is the Standard Creatine HCL Dose?

The recommended daily dose for creatine HCL is 1-2 grams. This is roughly half to one-third the standard monohydrate maintenance dose of 3-5 g/day.

The only peer-reviewed RCT testing creatine HCL used a weight-adjusted dose of 0.03 g/kg of body mass per day. For reference:

At these doses, the Eghbali et al. (2024) study found significant improvements in 1RM strength, skeletal muscle mass, muscle cross-sectional area, and body fat reduction over 8 weeks of resistance training, with results comparable to creatine monohydrate (Eghbali et al., 2024).

Does Creatine HCL Require a Loading Phase?

No loading phase is typically recommended for creatine HCL. This is one of the key practical differences from monohydrate protocols.

Traditional creatine monohydrate loading involves consuming 20 g/day (split into 4 doses of 5 g) for 5-7 days to rapidly saturate muscle creatine stores, followed by a 3-5 g/day maintenance dose. Loading is optional for monohydrate and simply accelerates saturation from 3-4 weeks to under one week.

In the Eghbali (2024) RCT, the creatine HCL group used only a maintenance-level dose (0.03 g/kg/day) for the full 8-week study. Their strength and body composition outcomes were statistically comparable to the monohydrate group that completed a 5-day loading phase at 0.3 g/kg/day (Eghbali et al., 2024).

The practical takeaway: start at your daily dose from day one. No need to spend a week taking 15-20 g/day and dealing with the GI discomfort that loading sometimes causes.

A caveat: whether creatine HCL actually achieves full muscle creatine saturation faster than monohydrate at equivalent low doses has not been measured via muscle biopsy. The Eghbali study measured performance and body composition outcomes, not intramuscular creatine content directly. It is possible that HCL simply reaches a “good enough” threshold at lower doses rather than fully saturating stores.

When Should You Take Creatine HCL?

Timing is not a major factor for any form of creatine. The performance benefits come from chronic muscle creatine saturation maintained through daily intake, not from an acute pre-workout effect.

Any consistent daily time works. Morning, afternoon, or evening. The ISSN position stand on creatine states that daily consistency matters more than timing (Kreider et al., 2017).

With food may be marginally better. Insulin stimulates creatine uptake into muscle cells through the CreaT1 transporter. Taking creatine HCL with a meal that contains carbohydrates or protein triggers an insulin response that may modestly enhance uptake. The practical significance of this effect is small, and the easiest approach is simply to take it with whatever meal you eat most reliably.

Pre- or post-workout is fine but not required. Some research on creatine in general suggests a very slight advantage to dosing close to a training session, potentially because increased blood flow to working muscles enhances uptake. The effect size is minimal. Choose whatever timing you will maintain without forgetting.

How Does the Dose Compare to Creatine Monohydrate?

The lower dose for creatine HCL is commonly attributed to its higher solubility, but solubility and bioavailability are distinct properties. Alraddadi et al. (2018) demonstrated that creatine monohydrate already has near-complete oral bioavailability in animal models (Alraddadi et al., 2018). The clinical evidence from Eghbali (2024) shows that creatine HCL at 0.03 g/kg produced comparable outcomes to monohydrate at 0.03 g/kg (without loading) and to monohydrate with loading. The dose difference between products on the market (1-2 g HCL vs. 3-5 g monohydrate) is largely a manufacturer recommendation, not a finding from dose-equivalency clinical trials.

Can You Take Too Much Creatine HCL?

The ISSN position stand on creatine reports no adverse effects from creatine supplementation at recommended doses in healthy individuals, with safety data extending to 5 years of continuous use (Kreider et al., 2017). This data is based on creatine monohydrate, not HCL specifically, but the active molecule is identical.

Taking doses well above 2 g/day of creatine HCL is unlikely to be dangerous, but there is no evidence it provides additional benefit. Muscle creatine storage has an upper limit. Once stores are saturated, excess creatine is simply excreted. Higher doses also increase the proportion of creatine converted to creatinine (a metabolic waste product), which raises serum creatinine on blood tests without indicating kidney damage.

If you are a larger individual (over 90 kg), the weight-adjusted dosing from the Eghbali study suggests a dose closer to 2.7-3 g/day may be appropriate. For most people under 90 kg, 2 g/day is a reasonable starting point.

Cycling and Long-Term Use?

There is no scientific basis for cycling creatine (taking it for a period, stopping, then resuming). The ISSN has specifically addressed this myth and found no evidence of creatine transporter downregulation, suppression of endogenous creatine synthesis, or rebound effects upon discontinuation (Kreider et al., 2017).

Take creatine HCL daily, consistently, indefinitely. If you stop, muscle creatine stores will gradually return to baseline levels over approximately 4-6 weeks. There are no withdrawal effects.

References

1. Eghbali E, Arazi H, Suzuki K. Supplementing with which form of creatine (hydrochloride or monohydrate) alongside resistance training can have more impacts on anabolic/catabolic hormones, strength and body composition? Physiol Res. 2024. 73(5):739-753. PMID: 39545789

2. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017. 14:18. PMID: 28615996

3. Alraddadi EA, et al. Absolute oral bioavailability of creatine monohydrate in rats: debunking a myth. Pharmaceutics. 2018. 10(1):31. PMID: 29518030